Inhalable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Inhalable Drug Delivery Pipeline Market Report Overview
An inhalable drug delivery device is meant to administer medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route.
The Inhalable Drug Delivery pipeline market research report provides comprehensive information about the inhalable drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.
Key Segments | · Nebulizer Systems
· Aqueous Systems |
Key Territories | · The US
· Europe · China · Canada · Australia · Singapore · South Korea · Taiwan · Thailand · Malaysia |
Key Regulatory Paths | · 510(k)
· CE · NMPA · MDL · TGA · HAS · ICAC · MDA · BOPA · MDITAC |
Leading Companies | · Ablynx NV
· Acorda Therapeutics Inc · Actervis GmbH · Aeon Research & Technology · Aerami Therapeutics Inc · Aerophase Inc · AFT Pharmaceuticals Ltd · Alexza Pharmaceuticals Inc · Ayuda Medical LLC · Baby’s Breath Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Inhalable Drug Delivery Pipeline Market by Segments
The key segments in the inhalable drug delivery pipeline market are nebulizer systems and aqueous systems. As of September 2023, the nebulizer system has a higher number of pipeline products.
Inhalable Drug Delivery Pipeline Market Analysis by Segments, 2023 (%)
Buy Full Report for More Segment Insights into the Inhalable Drug Delivery Pipeline Market
Inhalable Drug Delivery Pipeline Market Segmentation by Territories
Some of the key territories in the inhalable drug delivery market are the US, Europe, China, Canada, Australia, Singapore, South Korea, Taiwan, Thailand, and Malaysia. As of September 2023, the US has the highest number of pipeline products.
Inhalable Drug Delivery Pipeline Market Analysis by Territories, 2023 (%)
Buy Full Report for More Territory Insights into the Inhalable Drug Delivery Pipeline Market
Inhalable Drug Delivery Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths in the inhalable drug delivery pipeline market are 510(k), CE, NMPA, MDL, TGA, HSA, ICAC, MDA, BOPA, and MDITAC. As of September 2023, 510(k) is the most followed pathway for pipeline products in the market.
Inhalable Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2023 (%)
Buy Full Report for More Regulatory Path Insights into the Inhalable Drug Delivery Pipeline Market
Inhalable Drug Delivery Pipeline Market – Competitive Landscape
Some of the key companies in the inhalable drug delivery pipeline market are Ablynx NV, Acorda Therapeutics Inc, Actervis GmbH, Aeon Research & Technology, Aerami Therapeutics Inc, Aerophase Inc, AFT Pharmaceuticals Ltd, Alexza Pharmaceuticals Inc, Ayuda Medical LLC, and Baby’s Breath Ltd.
Ablynx NV: It is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. The company’s proprietary Nanobody platform allows the rapid generation and large-scale production of novel biological therapeutics that have the potential to be used in a wide range of human diseases. The company has research collaborations and significant partnerships with key pharmaceutical companies including Merck, Novartis, and Boehringer Ingelheim. Ablynx is headquartered in Ghent, Belgium.
Acorda Therapeutics Inc: It is a biopharmaceutical company that discovers, develops, and markets therapies for treating patients with neurological disorders. The company’s portfolio encompasses marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson’s taking levodopa or carbidopa who experience off episodes. Acorda is headquartered in Ardsley, New York, the US.
Inhalable Drug Delivery Pipeline Market Analysis by Companies, 2023
Buy Full Report for More Company Insights into the Inhalable Drug Delivery Pipeline Market
Segments Covered in the Report
Inhalable Drug Delivery Pipeline Market Segments Outlook
- Nebulizer Systems
- Aqueous Systems
Inhalable Drug Delivery Pipeline Market Territories Outlook
- The US
- Europe
- China
- Canada
- Australia
- Singapore
- South Korea
- Taiwan
- Thailand
- Malaysia
Inhalable Drug Delivery Pipeline Market Regulatory Paths Outlook
- 510(k)
- CE
- NMPA
- MDL
- TGA
- HAS
- ICAC
- MDA
- BOPA
- MDITAC
Scope
This report provides:
- Extensive coverage of the inhalable drug delivery under development.
- Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
- Reviews of major players involved in the development of inhalable drug delivery and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of inhalable drug delivery under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Acorda Therapeutics Inc
Actervis GmbH
Aeon Research & Technology
Aerami Therapeutics Inc
Aerophase Inc
AFT Pharmaceuticals Ltd
Alexza Pharmaceuticals Inc
Ayuda Medical LLC
Baby's Breath Ltd
Baxter International Inc
Bellerophon Therapeutics Inc
Breath Therapeutics Holding BV
Bridgesource Medical Corp
California Northstate University College of Medicine
Canigma A.L LTD
Cognigenics Inc
Creare LLC
Cybin Inc
Department of Biomedical Engineering Columbia University
DesignWise Medical Inc (Inactive)
Edixomed Ltd
HCmed Innovations Co Ltd
HOLLO Medical Inc
iDTx Systems, Inc.
Impel Pharmaceuticals Inc
Inhalation Sciences Sweden AB
Invero Pharma LLC
Jupiter Research LLC
KAER Biotherapeutics Corp
Kanabo Research Ltd
Lupin Pharmaceuticals Inc
Mallinckrodt Plc
Marquette University
Medspray BV
Monash University
Nemera La Verpilliere
Next Safety, Inc.
Nob Hill Therapeutics Inc
Nobilis Therapeutics Inc
Omron Healthcare Co Ltd
Omron Healthcare Inc
OncoSec Medical Inc
PARI GmbH
Parion Sciences Inc
Pharmosa Biopharm Inc
Respira Technologies Inc
Rhinomed Ltd
Risproly
RMIT University
Rutgers Cancer Institute of New Jersey
Sandoz International GmbH
Shenzhen Smoore Technology Ltd
Sino Biopharmaceutical Ltd
SolAeroMed Inc
Stevanato Group
Stirling Pharma Inc
Suzhou Wulian Medical Technology Co Ltd
Technology Commercialization Partners LLC
Teleflex Inc
Tetra Bio-Pharma Inc
Teva Pharmaceutical Industries Ltd
Texas Tech University Health Sciences Center
Third Pole Inc
Tiziana Life Sciences PLC
University Hospital Southampton NHS Foundation Trust
University of California San Diego
University of Texas Health Science Center at Houston
University of Texas Medical Branch at Galveston
Vectura Group Plc
Veoli Ltd
Vero Biotech LLC
Verona Pharma Plc
Via Therapeutics LLC
Vincent Medical Holdings Ltd
Virpax Pharmaceuticals Inc
VistaGen Therapeutics Inc
VitalMIST
Wellfully Ltd
Wellinks Inc
Windtree Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading segment in the inhalable drug delivery pipeline market?
Nebulizer system is the leading segment in the inhalable drug delivery pipeline market as of September 2023.
-
Which territory has the highest number of products in the inhalable drug delivery pipeline market?
As of September 2023, the US has the highest number of products in the inhalable drug delivery pipeline market.
-
Which is the most followed regulatory pathway in the inhalable drug delivery pipeline market?
As of September 2023, 510(k) is the most followed pathway for pipeline products in the inhalable drug delivery market.
-
Who are the major companies operating in the inhalable drug delivery pipeline market?
Some of the key companies in the inhalable drug delivery pipeline market are Ablynx NV, Acorda Therapeutics Inc, Actervis GmbH, Aeon Research & Technology, Aerami Therapeutics Inc, Aerophase Inc, AFT Pharmaceuticals Ltd, Alexza Pharmaceuticals Inc, Ayuda Medical LLC, and Baby’s Breath Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.